Skip to main content

Want a detailed portfolio tracker?

Kezar Life Sciences (KZR) P/E (2018 - 2026)

Kezar Life Sciences (KZR) P/E from Jun 21, 2018 to May 11, 2026. The TTM Kezar Life Sciences (KZR) P/E is -1.18. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Kezar Life Sciences (KZR)

YearP/EChange
2026-1.18+43.80%
2025-0.82+40.38%
2024-0.59-23.91%
2023-0.77-88.86%
2022-6.91-55.00%
2021-15.35+179.15%
2020-5.50+151.18%
2019-2.19-85.10%
2018-14.69N/A

Comparison Kezar Life Sciences (KZR) P/E with competitors

Kezar Life Sciences (KZR) P/E is -1.18.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.14%
NBYStablecoin Development Corp0.00-100.36%
ENLVEnlivex Ltd0.07-106.33%
FGENFibroGen Inc0.24-120.32%
CHRSCoherus Biosciences Inc0.85-171.83%
FBIOFortress Biotech Inc0.95-180.34%
ORMPOramed Pharmaceuticals Inc1.50-227.24%
AGENAgenus Inc3.01-354.79%
INVAInnoviva Inc3.15-367.01%
VXRTVaxart Inc3.55-400.51%
CRMDCorMedix Inc3.63-407.17%
CVACCureVac N.V.4.45-476.36%
GLPGGalapagos NV4.86-511.34%
SRPTSarepta Therapeutics Inc4.88-513.30%
ABEOAbeona Therapeutics Inc5.39-556.09%
ABUSArbutus Biopharma Corp5.60-573.71%
ZVRAZevra Therapeutics Inc5.89-598.39%
SPROSpero Therapeutics Inc6.23-627.28%
CGENCompugen Ltd6.31-634.52%
RIGLRigel Pharmaceuticals6.87-681.77%
SLXNSilexion Therapeutics Corp7.30-717.66%
OMEROmeros Corporation9.26-883.82%
AUPHAurinia Pharmaceuticals Inc9.58-911.43%
PLXProtalix BioTherapeutics Inc10.89-1022.00%
ACADAcadia Pharmaceuticals Inc11.73-1092.90%
TBPHTheravance Biopharma Inc12.26-1138.08%
ADMAAdma Biologics Inc12.42-1151.29%
HRMYHarmony Biosciences Holdings Inc13.82-1269.98%
SABSSAB Biotherapeutics Inc14.14-1296.73%
NAGENiagen Bioscience Inc14.82-1354.46%
INCYIncyte Corp15.82-1439.49%
REGNRegeneron Pharmaceuticals Inc15.86-1442.38%
PBYIPuma Biotechnology Inc17.32-1565.90%
CPRXCatalyst Pharmaceuticals Inc17.44-1576.36%
EXELExelixis Inc17.54-1584.72%
TGTXTG Therapeutics Inc18.97-1705.62%
MDXGMimedx Group Inc20.55-1839.92%
XOMAXOMA Royalty Corp22.87-2036.56%
ARGXArgen X SE24.30-2157.06%
CTMXCytomX Therapeutics Inc24.82-2201.34%
XOMAOXOMA Royalty Corp25.34-2245.68%
HALOHalozyme Therapeutics Inc25.62-2269.29%
XOMAPXOMA Royalty Corp25.67-2273.22%
VRTXVertex Pharmaceuticals Inc27.99-2470.02%
RPRXRoyalty Pharma plc - Class A28.69-2528.67%
SLNOSoleno Therapeutics Inc29.02-2556.43%
ASNDAscendis Pharma A/S30.09-2647.03%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3309.61%
APLSApellis Pharmaceuticals Inc39.02-3403.52%
BMRNBiomarin Pharmaceutical Inc42.21-3673.64%
KRYSKrystal Biotech Inc45.34-3938.76%
ONCBeiGene Ltd69.54-5987.27%
PHARPharming Group N.V.75.03-6451.64%
TECHBio-Techne Corp101.96-8731.76%
VCELVericel Corp109.92-9405.90%
ALNYAlnylam Pharmaceuticals Inc117.96-10086.88%
GMABGenmab140.29-11976.96%
TLXTelix Pharmaceuticals Ltd162.15-13827.80%
CORTCorcept Therapeutics Inc212.86-18120.44%